Interventional Effects of oral Liposomal Iron Supplementation in anemic and non anemic Iron-Deficiency Preschool Children: A Randomized, Double-Blind, Placebo-Controlled trial

menoufia faculty of medicine0 个研究点目标入组 45 人开始时间: 2023年12月24日最近更新: 2024年3月4日

适应症

试验速览

暂无简介。

•Age range 6 months till 59 months old at baseline screenin
•c–reactive protein (CRP) is negative at the start and also in follow-up analysis,
•Hb concentration is 7.0 g/dl or above, and heart rate within normal range
•no history of consumption of iron supplements for 4 months ago or history of blood transfusion,
•if anemia is found, no other causes rather than ID are present, the child has no chronic or acute diseases (except for asthma) over the time of follow-up.
•no hemolytic anemia established diagnosed hemoglobinopathy (e.g., sickle cell disease, beta thalassemia major), or neurological disability as cerebral palsy, developmental delay or fits.

•Children with a past history of prematurity, born small for date, or low birth weight below 2500 grams were excluded

发起方

menoufia faculty of medicine